Understanding Experiences of Recurrent Prostate Cancer Patients in Clinical Research
This observational study aims to understand the experiences of men with recurrent prostate cancer who participate in clinical research. Researchers want to learn how many patients decide to join a study and how many stay in the study until it's finished. This information will help improve future clinical trials for recurrent prostate cancer. You may be able to join if you are at least 18 years old, have recurrent prostate cancer, and can understand and sign a consent form. The study plans to include about 500 participants.
- Study design
- This is an observational study, meaning researchers will collect information without testing a specific treatment. It aims to enroll 500 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will measure participation at 3 months and completion rates at 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of patients who decide to participate in a recurrent prostate cancer clinical research3 months
- Rate of patients who remain in recurrent prostate cancer clinical research to trial completion12 months